Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tributyrin for Delirium Prevention in Mechanically Ventilated ICU Patients
ChiCTR2600123202Phase 2Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in delirium, acute kidney failure (AKF) and Healthcare-associated infection (HAI) comparing Tributyrin arm with Placebo arm (2 arms). Primary endpoints: Blood biomarker analysis at baseline, Gut microbiome analysis at baseline and 2 more. Started Apr 2026; status: recruiting.
02
Drugs
tributyrin
03
Conditions
deliriumacute kidney failure (AKF)Healthcare-associated infection (HAI)
Beyond the preview
Go deeper on ChiCTR2600123202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123202.